
Enable job alerts via email!
A leading cell and gene therapy CDMO in Bristol is seeking an Analytical Services Scientist to conduct analytical assays and support GMP processes. Key responsibilities include maintaining lab equipment, drafting SOPs, and adhering to GMP standards. Applicants should have a relevant BSc degree and over a year of experience in a regulated laboratory environment. Strong organizational and communication skills are essential, along with familiarity in analytical procedures such as HPLC and qPCR.
This is an exciting opportunity to work with eXmoor's globally recognised team of scientists, consultants and engineers. You will work on a wide range of Client projects in a rapidly growing business whilst developing your quality management career. The GMP manufacturing facility is capable of handling a wide range of cell and gene therapies as well as small scale complex biologics. The facility covers two technical areas (Process Development (PD) & GMP clinical phase production with an Analytical Services team supporting both Development and GMP), both working closely together such that processes developed in the PD area will be transferred at scale to the GMP suites. The AS Scientist will be responsible for conducting analytical assays in support of manufacturing and product release. The AS Scientist will also be responsible for supporting the development of methods and performing testing of process development samples in support of PD projects. The AS Scientist will be involved in the execution of validation protocols and collation of data to support method establishment for GMP programmes.
eXmoor Pharma is the only integrated cell and gene therapy CDMO with over 20 years of consultancy expertise embedded across every stage of the CMC journey - from early-phase strategy to process development, GMP manufacturing and commercialisation. We provide comprehensive support across Viral Vectors, Autologous and Allogeneic Cell Therapies, and RNA technologies. This integrated model enables seamless progression from early-phase strategy through to commercial readiness.